BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vicuron Pharmaceuticals, Inc. (Formerly Versicor) 

34790 Ardentech Court

Fremont  California  94555  U.S.A.
Phone: 510-739-3000 Fax: 510-739-3003


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Novartis Pharmaceuticals Corporation  Deformylase and MUR: Pathway inhibitors for novel mechanism based antimicrobial drugs

Pharmacia & Upjohn (Merged to form Pharmacia Corp)  Second generation antimicrobials for both community based and hospital markets





 Company News
Oscient Pharmaceuticals Corporation (OSCI) Acquires Expanded Worldwide Rights To Lead Clinical Candidate Ramoplanin 2/8/2006 10:41:13 AM    More...
East Bay Biotechs Hit Sales Block 1/3/2006 11:44:06 AM    More...
Vicuron Pharmaceuticals, Inc. (MICU) Extends Pfizer Inc. (PFE) Deal To Develop Oral Antibiotics For Community Market 10/19/2005 5:13:10 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) Announces Fourth Quarter 2004 Financial Results 10/19/2005 5:12:59 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The SG Cowen & Co., LLC 25th Annual Health Care Conference 10/19/2005 5:12:59 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) Provides Update On Novartis Pharma AG (NVS) Peptide Deformylase Inhibitor Program; Suspension Of Phase I First Lead Candidate In Favor Of Second Compound 10/19/2005 5:12:55 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The Wells Fargo Securities Healthcare Conference 10/19/2005 5:12:51 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) Granted Priority Review Of Dalbavancin NDA By FDA In Complicated Skin And Soft Tissue Infections 10/19/2005 5:12:49 PM    More...
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2005 10/19/2005 5:12:45 PM    More...
The Day In Review: Biotech Consolidates After Recent Gains 10/19/2005 5:12:38 PM    More...
12345678